PO Box 58871
London SE15 9BE, UK
+44 (0)7794 485294

Cedilla Publishing highly commended at 2016 BMA Medical Book Awards
We are delighted to announce that our GP pain handbook, The 10-minute consultation: persistent pain, was highly commended in the primary health care category at the 2016 BMA Medical Book Awards.

The GP judging panel commented:
"Pain management is an increasingly challenging field in general practice and this [guide] brings together a lot of useful information. It is comprehensive while concise and includes a good range from the best scientific evidence through to holistic approaches. I checked some of the sections and found them to be both accurate and up-to-date. It is a good introduction to the subject."

If you are interested in purchasing copies or translation rights, please contact Sarah Findlay on +44 (0)7794 485294 or email info@cedillapublishing.com.

News Archive

Child passive smoking 'increases chronic lung risk'
Sun, 19 Aug 2018 00:39:41 GMT
A study shows higher risk of fatal lung disease in adults exposed to cigarette smoke in childhood.
Rise in type 2 diabetes in young people in England and Wales
Sat, 18 Aug 2018 00:21:44 GMT
Child health experts say the rise is "alarming" and more should be done to reduce obesity.
E-cigarettes can be key weapon against smoking, say MPs
Fri, 17 Aug 2018 12:20:41 GMT
E-cigarettes are much less harmful than tobacco and shouldn't be treated the same way, MPs warn.
Don?t miss the 7 September deadline
Fri, 17 Aug 2018 12:49:45 +0100
The PharmaTimes Sales Awards closes for entry in just a few weeks and with Sanofi, Allergan, LEO Pharma, Novartis and Bio Products Laboratory and many more besides signed up to take part, all signs are pointing to a very exciting debut indeed. It only takes a few seconds to fill out the online entry form and entrants need not do anything else until the day of the competition.
News of the inaugural Medical & Scientific Excellence Awards is spreading fast
Fri, 17 Aug 2018 12:32:39 +0100
With the importance of MSLs, scientific advisors and medical information professionals growing year on year - PharmaTimes Media has recognised this burgeoning area and gathered together an array of experts within the field to devise a challenging and rewarding competition that now includes seven categories.
NICE sticks with ?no? for use of Perjeta after breast cancer surgery
Fri, 17 Aug 2018 10:57:25 +0100
NICE is sticking with its position that Roche’s Perjeta is not cost-effective enough to be used by the NHS post surgery to prevent breast cancer recurrence.